ASHLEY POOLE: Open Payments
NPI 1053848788 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$871 in 49 payments from 12 companies in 2025. Trend: 2023 $243 · 2024 $553 · 2025 $871
Food & beverage: $871
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 15 | $248 |
| ABBVIE INC. | 12 | $195 |
| Amgen Inc. | 5 | $99 |
| Exact Sciences Corporation | 4 | $88 |
| Lilly USA, LLC | 3 | $55 |
| Xeris Pharmaceuticals, Inc. | 2 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: QULIPTA, NURTEC ODT, ELIQUIS, Cologuard Collection Kit, UBRELVY, PREVNAR 20, EVENITY, MOUNJARO.
Industry payments across MD — which companies pay providers there.
